Insufficient scRNA-seq data for expression of CYP4F8 at single-cell level.
Insufficient scRNA-seq data for expression of CYP4F8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 82% | 2361.75 | 200 / 245 | 60% | 11.54 | 301 / 502 |
bladder | 67% | 329.71 | 14 / 21 | 38% | 22.46 | 189 / 504 |
breast | 36% | 293.90 | 165 / 459 | 32% | 9.12 | 358 / 1118 |
skin | 46% | 1066.89 | 825 / 1809 | 0% | 0.08 | 2 / 472 |
uterus | 1% | 1.05 | 2 / 170 | 12% | 2.94 | 53 / 459 |
pancreas | 1% | 1.45 | 4 / 328 | 4% | 1.61 | 8 / 178 |
intestine | 0% | 0.55 | 4 / 966 | 3% | 0.14 | 16 / 527 |
thymus | 2% | 3.28 | 11 / 653 | 1% | 0.05 | 6 / 605 |
esophagus | 0% | 0.49 | 4 / 1445 | 2% | 0.08 | 3 / 183 |
ovary | 1% | 0.21 | 1 / 180 | 1% | 0.02 | 5 / 430 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.05 | 4 / 286 |
lung | 0% | 0 | 0 / 578 | 1% | 0.05 | 7 / 1155 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.21 | 4 / 901 |
adipose | 0% | 0.32 | 4 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
heart | 0% | 0.22 | 2 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 0.06 | 2 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006690 | Biological process | icosanoid metabolic process |
GO_0006693 | Biological process | prostaglandin metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0018685 | Molecular function | alkane 1-monooxygenase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0070330 | Molecular function | aromatase activity |
Gene name | CYP4F8 |
Protein name | Cytochrome P450 4F8 (EC 1.14.14.1) (CYPIVF8) Cytochrome P450 family 4 subfamily F member 8 |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of endogenous polyunsaturated fatty acids (PUFAs) and their oxygenated derivatives (oxylipins). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon hydrogen bonds, with preference for omega-1 and omega-2 positions . Hydroxylates (5Z,8Z,11Z,14Z)-eicosatetraenoic acid (arachidonate) predominantly at omega-2 position to form (18R)-hydroxyeicosatetraenoic acid (18R-HETE) . Exhibits omega-1 hydroxylase activity toward prostaglandin (PG) H1, PGH2 and PGI2 . Catalyzes the epoxidation of double bonds of PUFAs, including docosahexaenoic and docosapentaenoic acids . Shows little activity against PGD2, PGE1, PGE2, PGF2alpha, and leukotriene B4. . |
Accessions | ENST00000612078.5 ENST00000589722.2 A0A087WUC9 ENST00000325723.10 A0A087WVG9 P98187 A0A087WZJ1 ENST00000617645.4 |